Home / Health / Constipation Drug Boosts Brain Fog After Depression
Constipation Drug Boosts Brain Fog After Depression
17 Jul
Summary
- Constipation drug prucalopride shows potential for cognitive enhancement.
- Study suggests targeting serotonin receptors may improve memory and focus.
- Early trial indicates no significant side effects from the medication.
A medication commonly prescribed for chronic constipation is showing early promise in addressing cognitive difficulties that persist after depression recovery. Researchers from the University of Birmingham and the University of Oxford conducted a small trial involving 50 adults who had previously experienced depression.
The study investigated prucalopride, a drug that activates a serotonin receptor (5-HT4) present in both the gut and the brain. Scientists theorized that stimulating this receptor could enhance cognitive performance, improving issues like memory problems and poor concentration, often referred to as 'brain fog'.
Participants receiving prucalopride demonstrated faster and more accurate responses on cognitive assessments compared to those who received a placebo. The trial, which lasted between seven and 10 days, reported no significant adverse side effects. Researchers emphasize that these findings are preliminary and larger studies are required before prucalopride can be considered a treatment for depression-related cognitive symptoms.
